ACE gene polymorphism in endemic nephropathy patients on chronic hemodialisys

Periodicum Biologorum

Volumn 102, Issue 1, 2000, Pages 73-76

  Jelaković, Bojan ^a   Sertić, Jadranka ^a   Čvorišćec, Dubravka ^a   Leko, Ninoslav ^b   Stavljenić Rukavina, Ana ^a   Kuzmanić, Duško ^a   Boršo, Gordana ^a   Laganović, Mario ^a   Baričić, Martin ^b   Čeović, Stjepan ^b  

^a KBC Zagreb   (Croatia)

^b DR JOSIP BEN EVI GENERAL HOSPITAL   (Croatia)

Author keywords

Angiotensin converting enzyme; Chronic renal failure; Endemic nephropathy; Gene polymorphism

Indexed keywords

ANGIOTENSIN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENDEMIC NEPHROPATHY; FEMALE; GENE FREQUENCY; GENOTYPE; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY;

EID: 0033918794     PISSN: 00315362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. ČEOVIĆ S, HRABAR A, RADONIĆ M 1986 An etiological approach to Balkan endemic nephropathy based on the investigation of two genetically different populations. Nephron 40: 175-179
2. th Symposium on endemic (Balkan) nephropathy, Niš, University of Niš, p 241-245
3. HARDEN P, GEDDES C, ROWE P et al. 1995 Polymorphism in angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 345: 1540-1542
4. HUSKIĆ J, KULENOVIĆ H, ČULO F 1996 Serum angiotensin-converting enzyme activity in patients with endemic nephropathy. Nephron 74: 120-124
5. IHLE B, WHITWORTH J, SHAHINFAR S et al. 1996 Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a control double-blind trial. Am J Kidney Dis 27: 489-495
6. KAMPER A L, HOLSTIN-RATHLOU N K, LEYSAAC P P et al. 1996 The influence of angiotensin-converting enzyme inhibition on renal tubular function in progressive chronic nephropathy. Am J Kidney Dis 28: 822-831
7. LAFAYETTE R, MAYER G, PARK S et al. 1992 Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90: 766-771
8. LEWIS E, HUNSICKER L, BAIN R et al. 1993 The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462
9. McLAUGHLIN K, HARDEN P, UEDA S et al. 1996 The role of genetic polymorphism of angiotensin-converting enzyme in the progression of renal diseases. Hypertension 28: 912-915
10. NAVIS G, DE JONG P, DE ZEEUW 1997 VD polymorphism of the angiotensin enzyme gene: a clue to heterogeneity in the progression of renal disease and in the renal response to therapy? Nephrol Dial Transplant 12: 1097-1100
11. PATEL R, ANSARI A 1979 Serum angiotensin converting enzyme activity in patients with Chronic renal failure on long term hemodialysis. Clin Chim Acta 92: 491-495
12. SCHMIDT A, KIENER H P, BARNAS U et al. 1996 Angiotensin-converting enzyme polymorphism in patients with terminal renal failure. J Am Soc Nephrol 7: 314-317
13. SILVERSTEIN E, BRUNSWICK J, RAO T et al. 1984 Increased serum angiotensin-converting enzyme in Chronic renal disease. Nephron 37: 296-300
14. WORLD HEALTH ORGANIZATION 1965 Memorandum. The endemic nephropathy of South-Eastern Europe. Bulletin WHO 32:441-448
15. YOSHIDA H, KAWAMURA T, MITARAI T et al. 1995 Role for the deletion polymorphism in the angiotensin converting enzyme gene in IgA nephropathy. J Am Soc Nephrol 5 (suppl 3): 846